Some of the content on this website requires JavaScript to be enabled in your web browser to function as intended.
This includes, but is not limited to: Flash (also requires the Adobe Flash Player), navigation, video, image galleries, etc. While
the website is still usable without JavaScript, it should be enabled to enjoy the full interactive experience.

Dr. Verkhivker is currently a Professor of Computational Biology. He is also an Adjunct Professor of Pharmacology at the Department of Pharmacology, UC San Diego. His research activities are in the areas of computational cancer biology, translational bioinformatics, and computational pharmacology. He received his PhD in Physical Chemistry from Moscow University and completed a postdoctoral fellowship in computational biophysics from University of Illinois at Chicago. In 2000-2005, Dr. Verkhivker has held various research and management positions at Pfizer Global Research and Development, San Diego. Since 2002, he has been Adjunct Professor of Pharmacology at the Skaggs School of Pharmacy and Pharmaceutical Sciences, UC San Diego. In 2006, he joined School of Pharmacy and Center for Bioinformatics, The University of Kansas as a Professor of Pharmaceutical Chemistry and Bioinformatics. Dr. Verkhivker returned to California in 2011 and joined Chapman University in August 2011 as a Full Professor of Computational Biology. Upon arrival to Chapman, Dr. Verkhivker has established a dynamic research group engaged in translational research that attracted a large cohort of undergraduate and graduate students. He has been involved in various global University initiatives and collaborations. Dr. Verkhivker has served on a number of important committees including Search Committee for new Found Dean of BioPharmacy School. He is also chairing the Doctoral Steering Committee of the newly approved PhD Graduate Program in Computational Sciences.

Google's long-term plan for extending human life. Verkhivker G. United Kingdom Centre for Policy Studies CapX • Sep 4, 2015.
CapX is a British online news website and aggregator founded by the Centre for Policy Studies that offers original content, and features opinion from a wide-range of thinkers on politics, economics, and business issues.